Concepts in gene therapy for cartilage repair

Injury

Volumn 39, Issue 1 SUPPL., 2008, Pages 97-113

  Steinert, Andre F ^a   Nöth, Ulrich ^a   Tuan, Rocky S ^b  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

Author keywords

Articular cartilage; Chondrocyte; Gene therapy; Growth factor; Mesenchymal stem cell

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; CHORDIN; COMPLEMENTARY DNA; FAS ANTIGEN; FAS LIGAND; FIBROBLAST GROWTH FACTOR 2; GROWTH FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR; NITRIC OXIDE; NOGGIN; PARATHYROID HORMONE RELATED PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PLASMID DNA; PLATELET DERIVED GROWTH FACTOR; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN KINASE B; SCATTER FACTOR; SMAD6 PROTEIN; SMAD7 PROTEIN; SOMATOMEDIN C; TRANSCRIPTION FACTOR SOX9; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNINDEXED DRUG; VIRUS VECTOR; WNT PROTEIN;

ARTICLE; ARTICULAR CARTILAGE; CELL PROTECTION; CELL REGENERATION; CELL TRANSPLANTATION; CELLULAR DISTRIBUTION; CHONDROPATHY; DNA DETERMINATION; GENE TARGETING; GENE THERAPY; GENE TRANSFER; HUMAN; HYALINE CARTILAGE; IN VIVO STUDY; MEDIATOR RELEASE; NONHUMAN; PRIORITY JOURNAL; TISSUE REGENERATION; WOUND HEALING;

CARTILAGE, ARTICULAR; CHONDROCYTES; CHONDROGENESIS; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; MESENCHYMAL STEM CELL TRANSPLANTATION; OSTEOARTHRITIS; REGENERATION; SYNOVIAL MEMBRANE; TISSUE ENGINEERING; TRANSFORMING GROWTH FACTOR BETA; WOUND HEALING;

EID: 39749111452     PISSN: 00201383     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.injury.2008.01.034     Document Type: Article

References (198)

1. Ahrens M., Ankenbauer T., Schroder D., et al. Expression of human bone morphogenetic proteins-2 or -4 in murine mesenchymal progenitor C3H10T1/2 cells induces differentiation into distinct mesenchymal cell lineages. DNA Cell Biol 12 10 (1993) 871-880
2. Alaaeddine N., Di Battista J.A., Pelletier J.P., et al. Differential effects of IL-8, LIF (pro-inflammatory) and IL-11 (anti-inflammatory) on TNF-alpha-induced PGE(2)release and on signaling pathways in human OA synovial fibroblasts. Cytokine 11 12 (1999) 1020-1030
3. Alaaeddine N., Di Battista J.A., Pelletier J.P., et al. Inhibition of tumor necrosis factor alpha-induced prostaglandin E2 production by the antiinflammatory cytokines interleukin-4, interleukin-10, and interleukin-13 in osteoarthritic synovial fibroblasts: distinct targeting in the signaling pathways. Arthritis Rheum 42 4 (1999) 710-718
4. Apparailly F., Verwaerde C., Jacquet C., et al. Adenovirusmediated transfer of viral IL-10 gene inhibitsmurine collageninduced arthritis. J Immunol 160 11 (1998) 5213-5220
5. Apparailly F., Millet V., Noel D., et al. Tetracycline-inducible interleukin- 10 gene transfer mediated by an adeno-associated virus: application to experimental arthritis. Hum Gene Ther 13 10 (2002) 1179-1188
6. Arai Y., Kubo T., Kobayashi K., et al. Adenovirus vector-mediated gene transduction to chondrocytes: in vitro evaluation of therapeutic efficacy of transforming growth factor-beta 1 and heat shock protein 70 gene transduction. J Rheumatol 24 9 (1997) 1787-1795
7. Ataliotis P. Platelet-derived growth factor A modulates limb chondrogenesis both in vivo and in vitro. Mech Dev 94 1-2 (2000) 13-24
8. Bakker A.C., Joosten L.A., Arntz O.J., et al. Prevention of murine collagen-induced arthritis in the knee and ipsilateral paw by local expression of human interleukin-1 receptor antagonist protein in the knee. Arthritis Rheum 40 5 (1997) 893-900
9. Baltzer A.W., and Lieberman J.R. Regional gene therapy to enhance bone repair. Gene Ther 11 4 (2004) 344-350
10. Bandara G., Mueller G.M., Galea-Lauri J., et al. Intraarticular expression of biologically active interleukin 1-receptor- antagonist protein by ex vivo gene transfer. Proc Natl Acad Sci USA 90 22 (1993) 10764-10768
11. Baragi V.M., Renkiewicz R.R., Jordan H., et al. Transplantation of transduced chondrocytes protects articular cartilage from interleukin 1-induced extracellular matrix degradation. J Clin Invest 96 5 (1995) 2454-2460
12. Baragi V.M., Renkiewicz R.R., Qiu L., et al. Transplantation of adenovirally transduced allogeneic chondrocytes into articular cartilage defects in vivo. Osteoarthritis Cartilage 5 4 (1997) 275-282
13. Barre L., Venkatesan N., Magdalou J., et al. Evidence of calciumdependent pathway in the regulation of human beta1,3- glucuronosyltransferase-1 (GlcAT-I) gene expression: a key enzyme in proteoglycan synthesis. Faseb J 20 10 (2006) 1692-1694
14. Barry F., Boynton R.E., Liu B., et al. Chondrogenic differentiation of mesenchymal stem cells from bone marrow: differentiation- dependent gene expression of matrix components. Exp Cell Res 268 2 (2001) 189-200
15. Behrens P., Bosch U., Bruns J., et al. [Indications and implementation of recommendations of the working group «Tissue Regeneration and Tissue Substitutes» for autologous chondrocyte transplantation (ACT)]. Z Orthop Ihre Grenzgeb 142 5 (2004) 529-539
16. Blanco F.J., Geng Y., and Lotz M. Differentiation-dependent effects of IL-1 and TGF-beta on human articular chondrocyte proliferation are related to inducible nitric oxide synthase expression. J Immunol 154 8 (1995) 4018-4026
17. Bonadio J., Smiley E., Patil P., et al. Localized, direct plasmid gene delivery in vivo: prolonged therapy results in reproducible tissue regeneration [see comments]. Nat Med 5 7 (1999) 753-759
18. Bonadio J. Tissue engineering via local gene delivery: update and future prospects for enhancing the technology. Adv Drug Deliv Rev 44 2-3 (2000) 185-194
19. Bouwmeester S.J., Beckers J.M., Kuijer R., et al. Long-term results of rib perichondrial grafts for repair of cartilage defects in the human knee. Int Orthop 21 5 (1997) 313-317
20. Brittberg M., Lindahl A., Nilsson A., et al. Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. N Engl J Med 331 14 (1994) 889-895
21. Buckwalter J.A. Articular cartilage: injuries and potential for healing. J Orthop Sports Phys Ther 28 4 (1998) 192-202
22. Buckwalter J.A., and Mankin H.J. Articular cartilage repair and transplantation. Arthritis Rheum 41 8 (1998) 1331-1342
23. Caplan A.I., Elyaderani M., Mochizuki Y., et al. Principles of cartilage repair and regeneration. Clin Orthop 342 (1997) 254-269
24. Caplan A.I. Mesenchymal stem cells and gene therapy. Clin Orthop 379 Suppl (2000) S67-S70
25. Caplan A.I., and Bruder S.P. Mesenchymal stem cells: building blocks for molecular medicine in the 21st century. Trends Mol Med 7 6 (2001) 259-264
26. Caplan A.I., and Dennis J.E. Mesenchymal stem cells as trophic mediators. J Cell Biochem 98 5 (2006) 1076-1084
27. Carlberg A.L., Pucci B., Rallapalli R., et al. Efficient chondrogenic differentiation of mesenchymal cells in micromass culture by retroviral gene transfer of BMP-2. Differentiation 67 4-5 (2001) 128-138
28. Chen F.H., Rousche K.T., Tuan R.S., and Technology. Insight: adult stem cells in cartilage regeneration and tissue engineering. Nat Clin Pract Rheumatol 2 7 (2006) 373-382
29. Chernajovsky Y., Adams G., Podhajcer O.L., et al. Inhibition of transfer of collagen-induced arthritis into SCID mice by ex vivo infection of spleen cells with retroviruses expressing soluble tumor necrosis factor receptor. Gene Ther 2 10 (1995) 731-735
30. Conway J.G., Andrews R.C., Beaudet B., et al. Inhibition of tumor necrosis factor-alpha (TNF-alpha) production and arthritis in the at by GW3333, a dual inhibitor of TNF-alpha-converting enzyme and matrix metalloproteinases. J Pharmacol Exp Ther 298 3 (2001) 900-908
31. Cucchiarini M., and Madry H. Gene therapy for cartilage defects. J Gene Med 7 12 (2005) 1495-1509
32. Cucchiarini M., Madry H., Ma C., et al. Improved tissue repair in articular cartilage defects in vivo by rAAV-mediated overexpression of human fibroblast growth factor 2. Mol Ther 12 2 (2005) 229-238
33. Cucchiarini M., Thurn T., WeimerA, et al. Restoration of the extracellular matrix in human osteoarthritic articular cartilage by overexpression of the transcription factor SOX9. Arthritis Rheum 56 1 (2007) 158-167
34. Dai Q., Manfield L., Wang Y., et al. Adenovirus-mediated gene transfer to healing tendon-enhanced efficiency using a gelatin sponge. J Orthop Res 21 (2003) 604-609
35. Dayer J.M. Interleukin 1 or tumor necrosis factor-alpha: which is the real target in rheumatoid arthritis?. J Rheumatol Suppl 65 (2002) 10-15
36. Denker A.E., Haas A.R., Nicoll S.B., et al. Chondrogenic differentiation of murine C3H10T1/2 multipotential mesenchymal cells: I. Stimulation by bone morphogenetic protein-2 in high-density micromass cultures. Differentiation 64 2 (1999) 67-76
37. Dharmavaram R.M., Liu G., Tuan R.S., et al. Stable transfection of human fetal chondrocytes with a type II procollagen minigene: expression of the mutant protein and alterations in the structure of the extracellular matrix in vitro. Arthritis Rheum 42 7 (1999) 1433-1442
38. Di Cesare P.E., Frenkel S.R., Carlson C.S., et al. Regional gene therapy for full-thickness articular cartilage lesions using naked DNA with a collagen matrix. J Orthop Res 24 5 (2006) 1118-1127
39. D'Lima D.D., Hashimoto S., Chen P.C., et al. Impact of mechanical trauma on matrix and cells. Clin Orthop Relat Res 391 Suppl (2001) S90-S99
40. D'Lima D.D., Hashimoto S., Chen P.C., et al. Prevention of chondrocyte apoptosis. J Bone Joint Surg Am 83-A Suppl 2 Pt 1 (2001) 25-26
41. D'Lima D.D., Hashimoto S., Chen P.C., et al. Cartilage injury induces chondrocyte apoptosis. J Bone Joint Surg Am 83-A Suppl 2 Pt 1 (2001) 19-21
42. Doherty P.J., Zhang H., Tremblay L., et al. Resurfacing of articular cartilage explants with genetically-modified human chondrocytes in vitro. Osteoarthritis Cartilage 6 3 (1998) 153-159
43. Ebert R., Ulmer M., Zeck S., et al. Selenium supplementation restores the antioxidative capacity and prevents cell damage in bonemarrow stromal cells in vitro. StemCells 24 5 (2006) 1226-1235
44. Enomoto H., Enomoto-Iwamoto M., Iwamoto M., et al. Cbfa1 is a positive regulatory factor in chondrocyte maturation. J Biol Chem 275 12 (2000) 8695-8702
45. Erdmann S., Muller W., Bahrami S., et al. Differential effects of parathyroid hormone fragments on collagen gene expression in chondrocytes. J Cell Biol 135 4 (1996) 1179-1191
46. Evans C.H., Robbins P.D., Ghivizzani S.C., et al. Clinical trial to assess the safety, feasibility, and efficacy of transferring a potentially anti-arthritic cytokine gene to human joints with rheumatoid arthritis. Hum Gene Ther 7 10 (1996) 1261-1280
47. Evans C.H., Gouze J.N., Gouze E., et al. Osteoarthritis gene therapy. Gene Ther 11 4 (2004) 379-389
48. Evans C.H., Pascher A., Betz O., et al. Genetically enhanced tissue engineering without cell culture or artificial scaffolds. In: Sandell A.J., and Grodzinsky L. (Eds). Orthopaedic Tissue Engineering (2004), AAOS, Rosemont, ILL 389-394
49. Evans C.H., Robbins P.D., Ghivizzani S.C., et al. Gene transfer to human joints: progress toward a gene therapy of arthritis. Proc Natl Acad Sci USA 102 24 (2005) 8698-8703
50. Evans C.H., Gouze E., Gouze J.N., et al. Gene therapeutic approaches-transfer in vivo. Adv Drug Deliv Rev 58 2 (2006) 243-258
51. Fischer L., Boland G., and Tuan R.S. Wnt-3A enhances bone morphogenetic protein-2-mediated chondrogenesis of murine C3H10T1/2 mesenchymal cells. J Biol Chem 277 34 (2002) 30870-30878
52. Fleischmann R.M., Schechtman J., Bennett R., et al. Anakinra, a recombinant human interleukin-1 receptor antagonist (rmetHuIL-1ra), in patients with rheumatoid arthritis: A large, international, multicenter, placebo-controlled trial. Arthritis Rheum 48 4 (2003) 927-934
53. Fortier L.A., Mohammed H.O., Lust G., et al. Insulin-like growth factor-I enhances cell-based repair of articular cartilage. J Bone Joint Surg Br 84 2 (2002) 276-288
54. Frisbie D.D., Ghivizzani S.C., Robbins P.D., et al. Treatment of experimental equine osteoarthritis by in vivo delivery of the equine interleukin-1 receptor antagonist gene. Gene Ther 9 1 (2002) 12-20
55. Fukumoto T., Sperling J.W., Sanyal A., et al. Combined effects of insulin-like growth factor-1 and transforming growth factorbeta1 on periostealmesenchymal cells during chondrogenesis in vitro. Osteoarthritis Cartilage 11 1 (2003) 55-64
56. Gelse K., Jiang Q.J., Aigner T., et al. Fibroblast-mediated delivery of growth factor complementary DNA into mouse joints induces chondrogenesis but avoids the disadvantages of direct viral gene transfer. Arthritis Rheum 44 8 (2001) 1943-1953
57. Gelse K., von der Mark K., Aigner T., et al. Articular cartilage repair by gene therapy using growth factor-producing mesenchymal cells. Arthritis Rheum 48 2 (2003) 430-441
58. Gelse K., and Schneider H. Ex vivo gene therapy approaches to cartilage repair. Adv Drug Deliv Rev 58 2 (2006) 259-284
59. Ghivizzani S.C., Kang R., Georgescu H.I., et al. Constitutive intraarticular expression of human IL-1 beta following gene transfer to rabbit synovium produces all major pathologies of human rheumatoid arthritis. J Immunol 159 7 (1997) 3604-3612
60. Ghivizzani S.C., Lechman E.R., Kang R., et al. Direct adenovirusmediated gene transfer of interleukin 1 and tumor necrosis factor alpha soluble receptors to rabbit knees with experimental arthritis has local and distal anti-arthritic effects. Proc Natl Acad Sci USA 95 8 (1998) 4613-4618
61. Ghivizzani S.C., Oligino T.J., Glorioso J.C., et al. Direct gene delivery strategies for the treatment rheumatoid arthritis. Drug Discovery Today 6 5 (2001) 236-244
62. Gouze E., Pawliuk R., Pilapil C., et al. In vivo gene delivery to synovium by lentiviral vectors. Mol Ther 5 4 (2002) 397-404
63. Gouze E., Pawliuk R., Gouze J.N., et al. Lentiviral-mediated gene delivery to synovium: potent intra-articular expression with amplification by inflammation. Mol Ther 7 4 (2003) 460-466
64. Gouze J.N., Gouze E., Palmer G.D., et al. A comparative study of the inhibitory effects of interleukin-1 receptor antagonist following administration as a recombinant protein or by gene transfer. Arthritis Res Ther 5 5 (2003) 301-309
65. Gouze J.N., Gouze E., Palmer G.D., et al. Adenovirus-mediated gene transfer of glutamine: fructose-6-phosphate amidotransferase antagonizes the effects of interleukin-1beta on rat chondrocytes. Osteoarthritis Cartilage 12 3 (2004) 217-224
66. Gouze J.N., Stoddart M.J., Gouze E., et al. In vitro gene transfer to chondrocytes and synovial fibroblasts by adenoviral vectors. Methods Mol Med 100 (2004) 147-164
67. Grande D.A., Mason J., Light E., et al. Stem cells as platforms for delivery of genes to enhance cartilage repair. J Bone Joint Surg Am 85-A Suppl 2 (2003) 111-116
68. Gruber R., Mayer C., Bobacz K., et al. Effects of cartilagederived morphogenetic proteins and osteogenic protein-1 on osteochondrogenic differentiation of periosteum-derived cells. Endocrinology 142 5 (2001) 2087-2094
69. Haleem-Smith H., Derfoul A., Okafor C., et al. Optimization of high-efficiency transfection of adult human mesenchymal stem cells in vitro. Mol Biotechnol 30 1 (2005) 9-20
70. Hanada K., Solchaga L.A., Caplan A.I., et al. BMP-2 induction and TGF-beta 1 modulation of rat periosteal cell chondrogenesis. J Cell Biochem 81 2 (2001) 284-294
71. Hangody L., and Fules P. Autologous osteochondral mosaicplasty for the treatment of full-thickness defects of weight-bearing joints: ten years of experimental and clinical experience. J Bone Joint Surg Am 85-A Suppl (2003) 225-232
72. Hannallah D., Peng H., Young B., et al. Retroviral delivery of Noggin inhibits the formation of heterotopic ossification induced by BMP-4, demineralized bonematrix, and trauma in an animal model. J Bone Joint Surg Am 86-A 1 (2004) 80-91
73. Haupt J.L., Frisbie D.D., McIlwraith C.W., et al. Dual transduction of insulin-like growth factor-I and interleukin-1 receptor antagonist protein controls cartilage degradation in an osteoarthritic culture model. J Orthop Res 23 1 (2005) 118-126
74. Hickey D.G., Frenkel S.R., and Di Cesare P.E. Clinical applications of growth factors for articular cartilage repair. Am J Orthop 32 2 (2003) 70-76
75. Hidaka C., Goodrich L.R., Chen C.T., et al. Acceleration of cartilage repair by genetically modified chondrocytes over expressing bone morphogenetic protein-7. J Orthop Res 21 4 (2003) 573-583
76. Hoffmann A., and Gross G. BMP signaling pathways in cartilage and bone formation. Crit Rev Eukaryot Gene Expr 11 1-3 (2001) 23-45
77. Hoffmann A., Czichos S., Kaps C., et al. The T-box transcription factor Brachyury mediates cartilage development in mesenchymal stem cell line C3H10T1/2. J Cell Sci 115 Pt 4 (2002) 769-781
78. HollerN, KataokaT, Bodmer J.L., et al. Development of improved soluble inhibitors of FasL and CD40L based on oligomerized receptors. J Immunol Methods 237 1-2 (2000) 159-173
79. Holler N., Zaru R., Micheau O., et al. Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule. Nat Immunol 1 6 (2000) 489-495
80. Hunziker E.B. Articular cartilage repair: basic science and clinical progress. Areviewof the current status and prospects. Osteoarthritis Cartilage 10 6 (2002) 432-463
81. Hwang S.G., Ryu J.H., Kim I.C., et al. Wnt-7a causes loss of differentiated phenotype and inhibits apoptosis of articular chondrocytes via different mechanisms. J Biol Chem 279 25 (2004) 26597-26604
82. Ikeda T., Kubo T., Arai Y., et al. Adenovirus mediated gene delivery to the joints of guinea pigs. J Rheumatol 25 9 (1998) 1666-1673
83. Ito Y., Bringas Jr. P., Mogharei A., et al. Receptor-regulated and inhibitory Smads are critical in regulating transforming growth factor beta-mediated Meckel's cartilage development. Dev Dyn 224 1 (2002) 69-78
84. Iwamoto M., Kitagaki J., Tamamura Y., et al. Runx2 expression and action in chondrocytes are regulated by retinoid signaling and parathyroid hormone-related peptide (PTHrP). Osteoarthritis Cartilage 11 1 (2003) 6-15
85. Iwasaki M., and Jikko A. LeAX. Age-dependent effects of hedgehog protein on chondrocytes. J Bone Joint Surg Br 81 6 (1999) 1076-1082
86. Jiang Y., Jahagirdar B.N., Reinhardt R.L., et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418 6893 (2002) 41-49
87. Jorgensen C., Apparailly F., Couret I., et al. Interleukin-4 and interleukin-10 are chondroprotective and decrease mononuclear cell recruitment in human rheumatoid synoviumin vivo. Immunology 93 4 (1998) 518-523
88. Kafienah W., Al-Fayez F., Hollander A.P., et al. Inhibition of cartilage degradation: a combined tissue engineering and gene therapy approach. Arthritis Rheum 48 3 (2003) 709-718
89. Kang R., Marui T., Ghivizzani S.C., et al. Ex vivo gene transfer to chondrocytes in full-thickness articular cartilage defects: a feasibility study. Osteoarthritis Cartilage 5 2 (1997) 139-143
90. Katayama R., Wakitani S., Tsumaki N., et al. Repair of articular cartilage defects in rabbits using CDMP1 gene-transfected autologous mesenchymal cells derived from bone marrow. Rheumatology (Oxford) 43 8 (2004) 980-985
91. Kaul G., Cucchiarini M., Arntzen D., et al. Local stimulation of articular cartilage repair by transplantation of encapsulated chondrocytes overexpressing human fibroblast growth factor 2 (FGF-2) in vivo. J Gene Med 8 1 (2006) 100-111
92. Kuo C.K., Li W.J., Mauck R.L., et al. Cartilage tissue engineering: its potential and uses. Curr Opin Rheumatol 18 1 (2006) 64-73
93. Kuroda R., Ishida K., Matsumoto T., et al. Treatment of a fullthickness articular cartilage defect in the femoral condyle of an athlete with autologous bone-marrow stromal cells. Osteoarthritis Cartilage 15 2 (2007) 226-231
94. Lechman E.R., Jaffurs D., Ghivizzani S.C., et al. Direct adenoviral gene transfer of viral IL-10 to rabbit knees with experimental arthritis ameliorates disease in both injected and contralateral control knees. J Immunol 163 4 (1999) 2202-2208
95. Lee K.H., Song S.U., Hwang T.S., et al. Regeneration of hyaline cartilage by cell-mediated gene therapy using transforming growth factor beta 1-producing fibroblasts. Hum Gene Ther 12 14 (2001) 1805-1813
96. Lefebvre V., Mukhopadhyay K., Zhou G., et al. A 47-bp sequence of the first intron of the mouse pro alpha 1(II) collagen gene is sufficient to direct chondrocyte Expression. Ann NY Acad Sci 785 (1996) 284-287
97. Lefebvre V., Li P., and de Crombrugghe B. A new long form of Sox5 (L-Sox5), Sox6 and Sox9 are coexpressed in chondrogenesis and cooperatively activate the type II collagen gene. Embo J 17 19 (1998) 5718-5733
98. Lefebvre V., Behringer R.R., and de Crombrugghe B. L-Sox5, Sox6 and Sox9 control essential steps of the chondrocyte differentiation pathway. Osteoarthritis Cartilage 9 Suppl A (2001) 69-75
99. Li Y., Tew S.R., Russell A.M., et al. Transduction of passaged human articular chondrocytes with adenoviral, retroviral, and lentiviral vectors and the effects of enhanced expression of SOX9. Tissue Eng 10 3-4 (2004) 575-584
100. Lian J.B., Stein G.S., Stein J.L., et al. Marrow transplantation and targeted gene therapy to the skeleton. ClinOrthop Relat Res 379 Suppl (2000) 146-155
101. Lotz M. The role of nitric oxide in articular cartilage damage. Rheum Dis Clin North Am 25 2 (1999) 269-282
102. Lotz M., Hashimoto S., and Kuhn K. Mechanisms of chondrocyte apoptosis. Osteoarthritis Cartilage 7 4 (1999) 389-391
103. Lotz M. Cytokines in cartilage injury and repair. Clin Orthop Relat Res 391 Suppl (2001) S108-S115
104. Lubberts E., Joosten L.A., van Den Bersselaar L., et al. Adenoviral vector-mediated overexpression of IL-4 in the knee joint of mice with collagen-induced arthritis prevents cartilage destruction. J Immunol 163 8 (1999) 4546-4556
105. Lubberts E., Joosten L.A., Van Den Bersselaar L., et al. Intraarticular IL-10 gene transfer regulates the expression of collagen-induced arthritis (CIA) in the knee and ipsilateral paw. Clin Exp Immunol 120 2 (2000) 375-383
106. Madry H., and Trippel S.B. Efficient lipid-mediated gene transfer to articular chondrocytes. Gene Ther 7 4 (2000) 286-291
107. Madry H., Zurakowski D., and Trippel S.B. Overexpression of human insulin-like growth factor-I promotes new tissue formation in an ex vivo model of articular chondrocyte transplantation. Gene Ther 8 19 (2001) 1443-1449
108. Madry H., Cucchiarini M., Stein U., et al. Sustained transgene expression in cartilage defects in vivo after transplantation of articular chondrocytes modified by lipid-mediated gene transfer in a gel suspension delivery system. J Gene Med 5 6 (2003) 502-509
109. Madry H., Emkey G., Zurakowski D., et al. Overexpression of human fibroblast growth factor 2 stimulates cell proliferation in an ex vivo model of articular chondrocyte transplantation. J Gene Med 6 2 (2004) 238-245
110. Madry H., Kaul G., Cucchiarini M., et al. Enhanced repair of articular cartilage defects in vivo by transplanted chondrocytes overexpressing insulin-like growth factor I (IGF-I). Gene Ther 12 15 (2005) 1171-1179
111. Maier R., Ganu V., and Lotz M. Interleukin-11, an inducible cytokine in human articular chondrocytes and synoviocytes, stimulates the production of the tissue inhibitor of metalloproteinases. J Biol Chem 268 29 (1993) 21527-21532
112. Maier R., Bilbe G., Rediske J., et al. Inducible nitric oxide synthase from human articular chondrocytes: cDNA cloning and analysis of mRNA expression. Biochim Biophys Acta 1208 1 (1994) 145-150
113. Makarov S.S., Olsen J.C., Johnston W.N., et al. Suppression of experimental arthritis by gene transfer of interleukin 1 receptor antagonist cDNA. Proc Natl Acad Sci USA 93 1 (1996) 402-406
114. Marlovits S., Zeller P., Singer P., et al. Cartilage repair: generations of autologous chondrocyte transplantation. Eur J Radiol 57 1 (2006) 24-31
115. Martin J.A., Klingelhutz A.J., Moussavi-Harami F., et al. Effects of oxidative damage and telomerase activity on human articular cartilage chondrocyte senescence. J Gerontol A Biol Sci Med Sci 59 4 (2004) 324-337
116. Mason J.M., Grande D.A., Barcia M., et al. Expression of human bone morphogenic protein 7 in primary rabbit periosteal cells: potential utility in gene therapy for osteochondral repair. Gene Ther 5 8 (1998) 1098-1104
117. Mason J.M., Breitbart A.S., Barcia M., et al. Cartilage and bone regeneration using gene-enhanced tissue engineering [In Process Citation]. Clin Orthop 379 Suppl (2000) 171-178
118. Merritt T.M., Alcorn J.L., Haynes R., et al. Expression of mutant cartilage oligomeric matrix protein in human chondrocytes induces the pseudoachondroplasia phenotype. JOrthop Res 24 4 (2006) 700-707
119. Mi Z., Ghivizzani S.C., Lechman E.R., et al. Adenovirus-mediated gene transfer of insulin-like growth factor 1 stimulates proteoglycan synthesis in rabbit joints. Arthritis Rheum 43 11 (2000) 2563-2570
120. Mi Z., Ghivizzani S.C., Lechman E., et al. Adverse effects of adenovirus-mediated gene transfer of human transforming growth factor beta 1 into rabbit knees. Arthritis Res Ther 5 3 (2003) 132-139
121. Minas T., and Nehrer S. Current concepts in the treatment of articular cartilage defects. Orthopedics 20 6 (1997) 525-538
122. Minas T. The role of cartilage repair techniques, including chondrocyte transplantation, in focal chondral knee damage. Instr Course Lect 48 (1999) 629-643
123. Minas T., and Peterson L. Advanced techniques in autologous chondrocyte transplantation. Clin Sports Med 18 1 (1999) 13-44
124. Minina E., Wenzel H.M., Kreschel C., et al. BMP and Ihh/ PTHrP signaling interact to coordinate chondrocyte proliferation and differentiation. Development 128 22 (2001) 4523-4534
125. Miura T., Mattson M.P., and Rao M.S. Cellular lifespan and senescence signaling in embryonic stem cells. Aging Cell 3 6 (2004) 333-343
126. Muller-Ladner U., Evans C.H., Franklin B.N., et al. Gene transfer of cytokine inhibitors into human synovial fibroblasts in the SCID mouse model. Arthritis Rheum 42 3 (1999) 490-497
127. Naski M.C., Colvin J.S., Coffin J.D., et al. Repression of hedgehog signaling and BMP4 expression in growth plate cartilage by fibroblast growth factor receptor 3. Development 125 24 (1998) 4977-4988
128. Naski M.C., and Ornitz D.M. FGF signaling in skeletal development. Front Biosci 3 (1998) 781-794
129. Neumann E., Judex M., Kullmann F., et al. Inhibition of cartilage destruction by double gene transfer of IL-1Ra and IL-10 involves the activin pathway. Gene Ther 9 22 (2002) 1508-1519
130. Nixon A.J., Fortier L.A., Williams J., et al. Enhanced repair of extensive articular defects by insulin-like growth factor-I-laden fibrin composites. J Orthop Res 17 4 (1999) 475-487
131. Nixon A.J., Saxer R.A., and Brower-Toland B.D. Exogenous insulinlike growth factor-I stimulates an autoinductive IGF-I autocrine/paracrine response in chondrocytes. J Orthop Res 19 1 (2001) 26-32
132. Nixon A.J., Haupt J.L., Frisbie D.D., et al. Gene-mediated restoration of cartilage matrix by combination insulin-like growth factor-I/interleukin-1 receptor antagonist therapy. Gene Ther 12 2 (2005) 177-186
133. Nochi H., Sung J.H., Lou J., et al. Adenovirus mediated BMP-13 gene transfer induces chondrogenic differentiation of murine mesenchymal progenitor cells. J Bone Miner Res 19 1 (2004) 111-122
134. Noth U., OsyczkaAM, Tuli R., et al. Multilineage mesenchymal differentiation potential of human trabecular bone-derived cells. J Orthop Res 20 5 (2002) 1060-1069
135. Noth U., Tuli R., Osyczka A.M., et al. In vitro engineered cartilage constructs produced by press-coating biodegradable polymer with human mesenchymal stem cells. Tissue Eng 8 1 (2002) 131-144
136. Oligino T.J., Yao Q., Ghivizzani S.C., et al. Vector systems for gene transfer to joints. Clin Orthop 379 Suppl (2000) 17-30
137. Oligino T.J., Ghivizzani S.C., Wolfe D., et al. Intra-articular delivery of a herpes simplex virus IL-1Ra gene vector reduces inflammation in a rabbit model of arthritis. Gene Ther 6 10 (1999) 1713-1720
138. Palmer G.D., Steinert A., Pascher A., et al. Gene-induced chondrogenesis of primary mesenchymal stem cells in vitro. Mol Therapy 12 2 (2005) 219-228
139. Park J., Gelse K., Frank S., et al. Transgene-activated mesenchymal cells for articular cartilage repair: a comparison of primary bone marrow-, perichondrium/periosteum- and fat-derived cells. J Gene Med 8 1 (2006) 112-125
140. Pascher A., Palmer G.D., Steinert A.F., et al. Gene delivery to cartilage defects using coagulated bone marrow aspirate. Gene Ther 11 2 (2004) 133-141
141. Pascher A., Steinert A.F., Palmer G.D., et al. Enhanced repair of the anterior cruciate ligament by in situ gene transfer: evaluation in an in vitro model. Mol Ther 10 2 (2004) 327-336
142. Pathi S., Rutenberg J.B., Johnson R.L., et al. Interaction of Ihh and BMP/Noggin signaling during cartilage differentiation. Dev Biol 209 2 (1999) 239-253
143. Pelletier J.P., Caron J.P., Evans C., et al. In vivo suppression of early experimental osteoarthritis by interleukin- 1 receptor antagonist using gene therapy. Arthritis Rheum 40 6 (1997) 1012-1019
144. Peterson L., Brittberg M., Kiviranta I., et al. Autologous chondrocyte transplantation. Biomechanics and long-term durability. Am J Sports Med 30 1 (2002) 2-12
145. Peterson L., Minas T., Brittberg M., et al. Treatment of osteochondritis dissecans of the knee with autologous chondrocyte transplantation: results at two to ten years. J Bone Joint Surg Am 85-A Suppl (2003) 217-224
146. Pittenger M.F., Mackay A.M., Beck S.C., et al. Multilineage potential of adult human mesenchymal stem cells. Science 284 5411 (1999) 143-147
147. Prockop D.J., and Sekiya IColter D.C. Isolation and characterization of rapidly self-renewing stem cells from cultures of human marrow stromal cells. Cytotherapy 3 5 (2001) 393-396
148. Robbins P.D., Evans C.H., and Chernajovsky Y. Gene therapy for arthritis. Gene Ther 10 10 (2003) 902-911
149. Rudolphi K., Gerwin N., Verzijl N., et al. Pralnacasan, an inhibitor of interleukin-1beta converting enzyme, reduces joint damage in two murine models of osteoarthritis. Osteoarthritis Cartilage 11 10 (2003) 738-746
150. Samuel R.E., Lee C.R., Ghivizzani S.C., et al. Delivery of plasmid DNA to articular chondrocytes via novel collagenglycosaminoglycan matrices. Hum Gene Ther 13 7 (2002) 791-802
151. Scharstuhl A., Diepens R., Lensen J., et al. Adenoviral overexpression of Smad-7 and Smad-6 differentially regulates TGFbeta- mediated chondrocyte proliferation and proteoglycan synthesis. Osteoarthritis Cartilage 11 11 (2003) 773-782
152. Scharstuhl A., Vitters E.L., van der Kraan P.M., et al. Reduction of osteophyte formation and synovial thickening by adenoviral overexpression of transforming growth factor beta/ bone morphogenetic protein inhibitors during experimental osteoarthritis. Arthritis Rheum 48 12 (2003) 3442-3451
153. Schmidt M.B., Chen E.H., and Lynch S.E. A review of the effects of insulin-like growth factor and platelet derived growth factor on in vivo cartilage healing and repair. Osteoarthritis Cartilage 14 5 (2006) 403-412
154. Sekiya I., Larson B.L., Vuoristo J.T., et al. Comparison of effect of BMP-2, -4, and -6 on in vitro cartilage formation of human adult stem cells from bone marrow stroma. Cell Tissue Res 320 2 (2005) 269-276
155. Sellers R.S., Zhang R., Glasson S.S., et al. Repair of articular cartilage defects one year after treatment with recombinant human bone morphogenetic protein-2 (rhBMP-2). J Bone Joint Surg Am 82 2 (2000) 151-160
156. Shortkroff S., and Yates K.E. Alteration of matrix glycosaminoglycans diminishes articular chondrocytes' response to a canonical Wnt signal. Osteoarthritis Cartilage 15 2 (2007) 147-154
157. Shuler F.D., Georgescu H.I., Niyibizi C., et al. Increased matrix synthesis following adenoviral transfer of a transforming growth factor beta1 gene into articular chondrocytes. J Orthop Res 18 4 (2000) 585-592
158. Smith N., Dong Y., Lian J.B., et al. Overlapping expression of Runx1(Cbfa2) and Runx2(Cbfa1) transcription factors supports cooperative induction of skeletal development. J Cell Physiol 203 1 (2005) 133-143
159. Smith P., Shuler F.D., Georgescu H.I., et al. Genetic enhancement of matrix synthesis by articular chondrocytes: comparison of different growth factor genes in the presence and absence of interleukin-1. Arthritis Rheum 43 5 (2000) 1156-1164
160. Song L., Chau L., Sakamoto Y., et al. Electric field-induced molecular vibration for noninvasive, high-efficiency DNA transfection. Mol Ther 9 4 (2004) 607-616
161. Steadman J.R., Rodkey W.G., and Rodrigo J.J. Microfracture: surgical technique and rehabilitation to treat chondral defects. Clin Orthop Relat Res 391 Suppl (2001) 362-369
162. Steadman J.R., Rodkey W.G., and Briggs K.K. Microfracture to treat full-thickness chondral defects: surgical technique, rehabilitation, and outcomes. J Knee Surg 15 3 (2002) 170-176
163. Steinert A., Weber M., Dimmler A., et al. Chondrogenic differentiation of mesenchymal progenitor cells encapsulated in ultrahigh-viscosity alginate. J Orthop Res 21 6 (2003) 1090-1097
164. Steinert A., Palmer G., Ghivizzani S.C., et al. Gene Therapy in the Treatment of Cartilage Injury. In: Mirzajan R. (Ed). Cartilage Injury in the Athlete (2006), Thieme Medical Publishers, New York 297-308
165. Tavella S., Biticchi R., Schito A., et al. Targeted expression of SHH affects chondrocyte differentiation, growth plate organization, and Sox9 expression. J Bone Miner Res 19 10 (2004) 1678-1688
166. Tew S., Redman S., Kwan A., et al. Differences in repair responses between immature and mature cartilage. Clin Orthop Relat Res 391 Suppl (2001) 142-152
167. Tew S.R., Li Y., Pothacharoen P., et al. Retroviral transduction with SOX9 enhances re-expression of the chondrocyte phenotype in passaged osteoarthritic human articular chondrocytes. Osteoarthritis Cartilage 13 1 (2005) 80-89
168. Thomas C.E., Ehrhardt A., and Kay M.A. Progress and problems with the use of viral vectors for gene therapy. Nat Rev Genet 4 5 (2003) 346-358
169. Tian H., and Stogiannidis I. Up-regulation of cartilage oligomeric matrix protein gene expression by insulin-like growth factor- I revealed by real-time reverse transcription-polymerase chain reaction. Acta Biochim Biophys Sin (Shanghai) 38 10 (2006) 677-682
170. Tomita T., Hashimoto H., Tomita N., et al. In vivo direct gene transfer into articular cartilage by intraarticular injection mediated by HVJ (Sendai virus) and liposomes. Arthritis Rheum 40 5 (1997) 901-906
171. Trippel S.B., Ghivizzani S.C., and Nixon A.J. Gene-based approaches for the repair of articular cartilage. Gene Ther 11 4 (2004) 351-359
172. Tsuchiya H., Kitoh H., Sugiura F., et al. Chondrogenesis enhanced by overexpression of sox9 gene in mouse bone marrow-derived mesenchymal stem cells. Biochem Biophys Res Commun 301 2 (2003) 338-343
173. Tsumaki N., Tanaka K., Arikawa-Hirasawa E., et al. Role of CDMP-1 in skeletal morphogenesis: promotion of mesenchymal cell recruitment and chondrocyte differentiation. J Cell Biol 144 1 (1999) 161-173
174. Tuan R. Boning up on telomerase. Nat Biotechnol 20 6 (2002) 560-561
175. Tuan R.S., Boland G., and Tuli R. Adult mesenchymal stem cells and cell-based tissue engineering. Arthritis Res Ther 5 1 (2003) 32-45
176. Tuan R.S. Stemming cartilage degeneration: adultmesenchymal stem cells as a cell source for articular cartilage tissue engineering. Arthritis Rheum 54 10 (2006) 3075-3078
177. Tuli R., Li W.J., and Tuan R.S. Current state of cartilage tissue engineering. Arthritis Res Ther 5 5 (2003) 235-238
178. Tuli R., Tuli S., Nandi S., et al. Transforming growth factorbeta- mediated chondrogenesis of human mesenchymal progenitor cells involves N-cadherin and mitogen-activated protein kinase and Wnt signaling cross-talk. J Biol Chem 278 42 (2003) 41227-41236
179. Tyler J.A. Insulin-like growth factor 1 can decrease degradation and promote synthesis of proteoglycan in cartilage exposed to cytokines. Biochem J 260 2 (1989) 543-548
180. Valhmu W.B., Palmer G.D., Dobson J., et al. Regulatory activities of the 5′- and 3′-untranslated regions and promoter of the human aggrecan gene. J Biol Chem 273 11 (1998) 6196-6202
181. van Osch G.J., van den Berg W.B., Hunziker E.B., et al. Differential effects of IGF-1 and TGF beta-2 on the assembly of proteoglycans in pericellular and territorial matrix by cultured bovine articular chondrocytes. Osteoarthritis Cartilage 6 3 (1998) 187-195
182. Venkatesan N., Barre L., Benani A., et al. Stimulation of proteoglycan synthesis by glucuronosyltransferase-I gene delivery: a strategy to promote cartilage repair. Proc Natl Acad Sci USA 101 52 (2004) 18087-18092
183. Vivien D., Galera P., Lebrun E., et al. Differential effects of transforming growth factor-beta and epidermal growth factor on the cell cycle of cultured rabbit articular chondrocytes. J Cell Physiol 143 3 (1990) 534-545
184. VortkampA, Lee K., Lanske B., et al. Regulation of rate of cartilage differentiation by Indian hedgehog and PTH-related protein. Science 273 5275 (1996) 613-622
185. Vortkamp A. Interaction of growth factors regulating chondrocyte differentiation in the developing embryo. Osteoarthritis Cartilage 9 Suppl (2001) 109-117
186. Wakitani S., Imoto K., Kimura T., et al. Hepatocyte growth factor facilitates cartilage repair. Full thickness articular cartilage defect studied in rabbit knees. Acta Orthop Scand 68 5 (1997) 474-480
187. Wakitani S., Mitsuoka T., Nakamura N., et al. Autologous bone marrow stromal cell transplantation for repair of fullthickness articular cartilage defects in human patellae: two case reports. Cell Transplant 13 5 (2004) 595-600
188. Weisser J., Rahfoth B., Timmermann A., et al. Role of growth factors in rabbit articular cartilage repair by chondrocytes in agarose. Osteoarthritis Cartilage 9 Suppl (2001) 48-54
189. Whalen J.D., Lechman E.L., Carlos C.A., et al. Adenoviral transfer of the viral IL-10 gene periarticularly to mouse paws suppresses development of collagen-induced arthritis in both injected and uninjected paws. J Immunol 162 6 (1999) 3625-3632
190. Worster A.A., Brower-Toland B.D., Fortier L.A., et al. Chondrocytic differentiation of mesenchymal stem cells sequentially exposed to transforming growth factor-beta1 in monolayer and insulin-like growth factor-I in a three-dimensional matrix. J Orthop Res 19 4 (2001) 738-749
191. Xie W.F., Zhang X., Sakano S., et al. Trans-activation of the mouse cartilage-derived retinoic acid-sensitive protein gene by Sox9. J Bone Miner Res 14 5 (1999) 757-763
192. Yao Q., Glorioso J.C., Evans C.H., et al. Adenoviral mediated delivery of FAS ligand to arthritic joints causes extensive apoptosis in the synovial lining. J Gene Med 2 3 (2000) 210-219
193. Yao Q., Wang S., Gambotto A., et al. Intra-articular adenoviralmediated gene transfer of trail induces apoptosis of arthritic rabbit synovium. Gene Ther 10 12 (2003) 1055-1060
194. Yokoo N., Saito T., Uesugi M., et al. Repair of articular cartilage defect by autologous transplantation of basic fibroblast growth factor gene-transduced chondrocytes with adeno-associated virus vector. Arthritis Rheum 52 1 (2005) 164-170
195. Yoo J.U., Barthel T.S., Nishimura K., et al. The chondrogenic potential of human bone-marrow-derived mesenchymal progenitor cells. J Bone Joint Surg Am 80 12 (1998) 1745-1757
196. Yoo J.U., Mandell I., Angele P., et al. Chondrogenitor cells and gene therapy. Clin Orthop 379 Suppl (2000) S164-S170
197. Zhou G., Lefebvre V., Zhang Z., et al. Three high mobility group-like sequences within a 48-base pair enhancer of the Col2a1 gene are required for cartilage-specific expression in vivo. J Biol Chem 273 24 (1998) 14989-14997
198. Zuk P.A., Zhu M., Mizuno H., et al. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 7 2 (2001) 211-228